Abstract
Abstract
Background
This study aimed to investigate the impact of tobacco industry interference on the implementation and management of tobacco control and the tobacco epidemic using the Tobacco Industry Interference Index (TIII) and MPOWER—a package of measures for tobacco control—and adult daily smoking prevalence in 30 countries.
Methods
The TIII was extracted from the Global Tobacco Industry Interference Index 2019 and Global Center for Good Governance in Tobacco Control (GGTC). MPOWER measures and adult daily smoking prevalence rate were extracted from the World Health Organization (WHO) report on the global tobacco epidemic in 2021. We assessed the ecological cross-lagged association between TIII and MPOWER scores and between TIII and age-standardized prevalence rates for adult daily tobacco users.
Results
Tobacco industry interference was inversely correlated with a country’s package of tobacco control measures (β = -0.088, P = 0.035). The TIII was correlated with weaker warnings about the dangers of tobacco (β = -0.016, P = 0.078) and lack of enforcement of bans on tobacco advertising promotion and sponsorship (β = -0.023, P = 0.026). In turn, the higher the TIII, the higher the age-standardized prevalence of adult daily tobacco smokers for both sexes (β = 0.170, P = 0.036). Adult daily smoking prevalence in males (β = 0.417, P = 0.004) was higher in countries where the tobacco industry received incentives that benefited its business.
Conclusion
Where the interference of the tobacco industries was high, national compliance with the Framework Convention on Tobacco Control (FCTC) was lower, and the prevalence of adult daily smokers higher. National governments and global society must work together to minimize the tobacco industry’s efforts to interfere with tobacco control policies.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, Borzouei S. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49. https://doi.org/10.1016/S0140-6736(20)30752-2.
2. Bialous SA. Impact of implementation of the WHO FCTC on the tobacco industry’s behaviour. Tob Control. 2019;28(Suppl 2):s94–6. https://doi.org/10.1136/tobaccocontrol-2018-054808.
3. World Health Organization. (2008). MPOWER: a policy package to reverse the tobacco epidemic. Geneva: World Health Organization. Available: https://apps.who.int/iris/handle/10665/43888 Accessed 20 May 2023.
4. Dubray J, Schwartz R, Chaiton M, O’Connor S, Cohen JE. The effect of MPOWER on smoking prevalence. Tob Control. 2015;24(6):540–2. https://doi.org/10.1136/tobaccocontrol-2014-051834.
5. Husain MJ, Datta BK, Nargis N, Iglesias R, Perucic AM, Ahluwalia IB, Richter P. Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008–2017. Tobacco Control. 2021;30(6):630–7. https://doi.org/10.1136/tobaccocontrol-2020-055758.